In March 2025, the company announced new ideas for the direct-to-customer presenting of its Wegovy weight loss drug. The company established a brand new pharmacy, known as NovoCare, which would charge customers $499 per month for access to the drug, below 50 percent the price of the drug by means of other pharmaceutical distribution networks.[53]Ry